|
KDM5B expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.272400E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.072800E-01 |
| Normal-vs-Stage2 |
5.815200E-01 |
| Normal-vs-Stage3 |
1.886190E-01 |
| Normal-vs-Stage4 |
6.357800E-01 |
| Stage1-vs-Stage2 |
8.032800E-01 |
| Stage1-vs-Stage3 |
1.239990E-01 |
| Stage1-vs-Stage4 |
4.286800E-01 |
| Stage2-vs-Stage3 |
1.222400E-01 |
| Stage2-vs-Stage4 |
4.057200E-01 |
| Stage3-vs-Stage4 |
6.927800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.612400E-01 |
| Normal-vs-AfricanAmerican |
8.675200E-01 |
| Normal-vs-Asian |
9.955000E-01 |
| Caucasian-vs-AfricanAmerican |
3.205800E-01 |
| Caucasian-vs-Asian |
8.275000E-01 |
| AfricanAmerican-vs-Asian |
9.383000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.334000E-01 |
| Normal-vs-Female |
5.339300E-03 |
| Male-vs-Female |
6.238100E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.843000E-01 |
| Normal-vs-Extreme_Weight |
1.891640E-01 |
| Normal-vs-Obese |
1.878370E-01 |
| Normal-vs-Extreme_Obese |
4.154600E-01 |
| Normal_Weight-vs-Extreme_Weight |
1.467410E-01 |
| Normal_Weight-vs-Obese |
3.843200E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.699400E-01 |
| Extreme_Weight-vs-Obese |
8.622700E-03 |
| Extreme_Weight-vs-Extreme_Obese |
9.659800E-01 |
| Obese-vs-Extreme_Obese |
2.367200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.063600E-02 |
| Normal-vs-Age(41-60Yrs) |
9.589600E-02 |
| Normal-vs-Age(61-80Yrs) |
5.363800E-01 |
| Normal-vs-Age(81-100Yrs) |
2.257500E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.201200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.129600E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.516500E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.855300E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.08929999999663E-05 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.016200E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
8.941400E-01 |
| Normal-VS-Type2 PRCC |
1.733800E-01 |
| Normal-VS-KIRP CIMP |
3.924300E-02 |
| Normal-VS-Unclassified PRCC |
2.787400E-01 |
| Type1 PRCC-VS-Type2 PRCC |
6.650000E-02 |
| Type1 PRCC-VS-KIRP CIMP |
3.938000E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
2.740800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.141900E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
2.854200E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
7.973900E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.262300E-02 |
| Normal-vs-N1 |
1.398420E-02 |
| Normal-vs-N2 |
2.032000E-01 |
| N0-vs-N1 |
1.542890E-03 |
| N0-vs-N2 |
1.282040E-01 |
| N1-vs-N2 |
8.659000E-01 |
|
|
